Duloxetine in the treatment of irritable
β
Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha
π
Article
π
2009
π
John Wiley and Sons
π
English
β 94 KB
π 2 views
## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an openβlabel 12βweek trial of duloxetine 60βmg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal